About Us |
Contact Us |
LexisNexis Business Solutions
Faced with increasing globalization and supply chain complexity, pharmaceutical companies have the daunting task of managing risks—ranging from counterfeiting to piracy—that could potentially threaten patient safety. What’s more, the pharmaceutical industry is not immune to the impact...
Last week, Mark Dunn, the due diligence segment leader for Risk and Compliance at LexisNexis, offered his insights during an ISM Webinar entitled “Mitigating Risks and Impact of Sanctions Regimes on Your Supply Chain.” It’s a growing area of concern, but as Kelly Barner noted in the...